Logo image of AAGR

AFRICAN AGRICULTURE HOLDINGS (AAGR) Stock Fundamental Analysis

NASDAQ:AAGR - Nasdaq - US00792J1007 - Common Stock - Currency: USD

0.1326  -0.01 (-9.05%)

After market: 0.0627 -0.07 (-52.71%)

Fundamental Rating

0

Taking everything into account, AAGR scores 0 out of 10 in our fundamental rating. AAGR was compared to 89 industry peers in the Food Products industry. AAGR may be in some trouble as it scores bad on both profitability and health. AAGR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AAGR has reported negative net income.
In the past year AAGR has reported a negative cash flow from operations.
AAGR Yearly Net Income VS EBIT VS OCF VS FCFAAGR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 -2M -4M -6M -8M -10M

1.2 Ratios

AAGR's Return On Assets of -20.08% is on the low side compared to the rest of the industry. AAGR is outperformed by 76.09% of its industry peers.
AAGR has a worse Return On Equity (-294.89%) than 88.04% of its industry peers.
Industry RankSector Rank
ROA -20.08%
ROE -294.89%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AAGR Yearly ROA, ROE, ROICAAGR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 -5 -10 -15 -20 -25

1.3 Margins

AAGR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AAGR Yearly Profit, Operating, Gross MarginsAAGR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, AAGR has less shares outstanding
AAGR has a worse debt/assets ratio than last year.
AAGR Yearly Shares OutstandingAAGR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 5M 10M 15M 20M 25M
AAGR Yearly Total Debt VS Total AssetsAAGR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -2.70, we must say that AAGR is in the distress zone and has some risk of bankruptcy.
AAGR's Altman-Z score of -2.70 is on the low side compared to the rest of the industry. AAGR is outperformed by 80.43% of its industry peers.
A Debt/Equity ratio of 1.06 is on the high side and indicates that AAGR has dependencies on debt financing.
With a Debt to Equity ratio value of 1.06, AAGR is not doing good in the industry: 73.91% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Altman-Z -2.7
ROIC/WACCN/A
WACCN/A
AAGR Yearly LT Debt VS Equity VS FCFAAGR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.01 indicates that AAGR may have some problems paying its short term obligations.
AAGR has a worse Current ratio (0.01) than 97.83% of its industry peers.
AAGR has a Quick Ratio of 0.01. This is a bad value and indicates that AAGR is not financially healthy enough and could expect problems in meeting its short term obligations.
AAGR's Quick ratio of 0.01 is on the low side compared to the rest of the industry. AAGR is outperformed by 97.83% of its industry peers.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
AAGR Yearly Current Assets VS Current LiabilitesAAGR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for AAGR have decreased strongly by -12.21% in the last year.
EPS 1Y (TTM)-12.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-180.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AAGR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AAGR Price Earnings VS Forward Price EarningsAAGR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AAGR Per share dataAAGR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AAGR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AFRICAN AGRICULTURE HOLDINGS

NASDAQ:AAGR (9/25/2024, 8:00:00 PM)

After market: 0.0627 -0.07 (-52.71%)

0.1326

-0.01 (-9.05%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.47%
Inst Owner Change3.84%
Ins Owners56.21%
Ins Owner Change0%
Market Cap7.67M
AnalystsN/A
Price TargetN/A
Short Float %0.41%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5
P/tB 5
EV/EBITDA N/A
EPS(TTM)-0.31
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.08%
ROE -294.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z -2.7
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-180.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-204.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-204.76%
OCF growth 3YN/A
OCF growth 5YN/A